Solifenacin succinate 5 mg/1 (Solifenacin Succinate TABLET, FILM COATED) 5 mg/1

Solifenacin succinate 5 mg tablets are used to manage overactive bladder symptoms. This medication helps control bladder contractions, reducing urgency and frequency. Learn more about solifenacin succinate uses and benefits.

Strength

5 mg/1

Pack Size

90 TABLET, FILM COATED in 1 BOTTLE (0591-3795-19)

Manufacturer / TM Owner

Actavis Pharma, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Solifenacin succinate is primarily used to treat symptoms of overactive bladder, such as urinary urgency, frequency, and incontinence. It works by relaxing the bladder muscles, helping to improve bladder control. People often ask, 'What is solifenacin succinate used for?' This medication is designed to alleviate discomfort and improve quality of life for those experiencing bladder control issues.

Side Effects

Common effects of solifenacin succinate may include dry mouth, constipation, and blurred vision. Some users might experience dizziness or headaches. These effects can vary from person to person and are generally mild to moderate in nature.

Precautions & Warnings

Solifenacin succinate should be handled with care, especially by individuals with certain medical conditions like glaucoma or urinary retention. It is important to follow the advice of a healthcare professional regarding its use. Always store the medication as directed to maintain its effectiveness.

Avoid Interactions

Solifenacin succinate may interact with other medications, particularly those that affect the central nervous system or cause drowsiness. It is advisable to consult a healthcare provider before combining it with alcohol or other substances that can cause similar effects.

References

Frequently Asked Questions

Solifenacin succinate is used to manage symptoms of overactive bladder, such as urinary urgency and frequency.

Solifenacin succinate tablets are typically taken orally, with or without food, as directed by a healthcare professional.

Common side effects may include dry mouth, constipation, and blurred vision.

It is important to consult a healthcare provider before combining solifenacin succinate with other medications to avoid potential interactions.

Solifenacin succinate may not be suitable for individuals with certain medical conditions, such as glaucoma or urinary retention.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.